율피 추출물 및 라벤더 워터를 함유하는 아토피 개선용 피부 외용제 조성물
    62.
    发明公开
    율피 추출물 및 라벤더 워터를 함유하는 아토피 개선용 피부 외용제 조성물 有权
    用于对含有牛肉内胆提取物和漂洗水的天然植物提取物进行皮肤外用施用的组合物

    公开(公告)号:KR1020110049980A

    公开(公告)日:2011-05-13

    申请号:KR1020090106773

    申请日:2009-11-06

    CPC classification number: A61K36/49 A61K8/97 A61K36/53 A61Q19/005 Y10S514/857

    Abstract: PURPOSE: An external use skin composition containing chestnut inner bark extract and lavender water is provided to suppress proteinase-activated receptor-2 activation. CONSTITUTION: An external use skin composition for treating atopic dermatitis contains 0.001-50 weight% of chestnut inner bark extract and 0.001-50 weight% of lavender water. The chestnut inner bark extract is obtained by agitation of dried chestnut inner bark in the water at room temperature, filtering, and concentrating the extract. The lavender water is obtained by repeating steps of steaming hot steam vapor to the lavender flower and concentrating. The composition further contains 0.01-15 weight% of ingredient selected from the group consisting of xylitol, anhydrous xylitol, xylitylglucosdie, dextri, rye extract, and Hamamelis extract.

    Abstract translation: 目的:提供含有栗子内皮提取物和薰衣草水的外用皮肤组合物,以抑制蛋白酶激活的受体-2激活。 构成:用于治疗特应性皮炎的外用皮肤组合物含有0.001-50重量%的栗子内皮提取物和0.001-50重量%的薰衣草水。 板栗内皮提取物通过在室温下搅拌干燥的栗子内皮在水中得到,过滤并浓缩提取物。 薰衣草水通过重复将热蒸气蒸汽蒸发到薰衣草花并进行浓缩的步骤获得。 该组合物还含有0.01-15重量%的选自木糖醇,无水木糖醇,木糖基葡萄糖苷,葡聚糖,黑麦提取物和金缕梅提取物的成分。

    율피 추출물을 포함하는 모발용 화장료 조성물
    64.
    发明公开
    율피 추출물을 포함하는 모발용 화장료 조성물 有权
    化妆品组合物,用于包装芝士内胆提取物

    公开(公告)号:KR1020100136308A

    公开(公告)日:2010-12-28

    申请号:KR1020090054598

    申请日:2009-06-18

    Abstract: PURPOSE: A cosmetic composition containing Chestnut Inner Bark extract for hair care is provided to stabilize sensitive, irritative, and/or reactive scalp. CONSTITUTION: A cosmetic composition for hair care contains Chestnut Inner Bark extract as an active ingredient. The composition further contains green tea extract, pine needle extract, or ginkgo leaf extract as active ingredient. The active ingredient is contained in 0.01-10.0 weight% based on total weight. The composition is manufactured in the form of hair tonic, hair essence, hair serum, hair treatment, hair conditioner, hair shampoo, or hair lotion.

    Abstract translation: 目的:提供含有用于头发护理的栗子内皮提取物的化妆品组合物以稳定敏感,刺激性和/或反应性头皮。 构成:用于护发的化妆品组合物含有栗子内皮提取物作为活性成分。 该组合物还含有绿茶提取物,松针提取物或银杏叶提取物作为活性成分。 活性成分以总重量计为0.01-10.0重量%。 该组合物以头发补品,头发精华,头发血清,头发处理,护发素,洗发剂或洗发剂的形式制造。

    항균성 펩티드의 발현을 회복시키기 위한 스핑고실포스포릴콜린 길항제의 용도
    66.
    发明公开
    항균성 펩티드의 발현을 회복시키기 위한 스핑고실포스포릴콜린 길항제의 용도 有权
    用于恢复抗微生物肽表达的SPHINGOSYLPHOSPHORLCHOLINE ANTAGONIST的使用

    公开(公告)号:KR1020090016595A

    公开(公告)日:2009-02-16

    申请号:KR1020087030865

    申请日:2006-12-08

    Abstract: A sphingosylphosphorylcholine(SPC) antagonist is provided to prevent and treat diseases related to the expression decrease of anti-bacterial peptide such as atopic dermatitis, and screen the SPC antagonist by analyzing the expression recover of gene or protein of the anti-bacterial peptide. The sphingosylphosphorylcholine(SPC) antagonist manufactures the medicine for restoring the expression of anti-bacterial peptide back to the normal level in mammal requiring the expression restoration of anti-bacterial peptide. The screening method of the sphingosylphosphorylcholine(SPC) antagonist comprises the steps of: treating the object with sphingosylphosphorylcholine or its derivative to inhibit expression of anti-bacterial peptide; and treating the object with the SPC antagonist candidate material, and analyzing the expression restoration level of the anti-bacterial peptide in the object.

    Abstract translation: 提供鞘糖基磷酰胆碱(SPC)拮抗剂以预防和治疗与抗细菌肽如特应性皮炎的表达降低相关的疾病,并通过分析抗细菌肽的基因或蛋白质的表达恢复来筛选SPC拮抗剂。 鞘氨醇磷酰胆碱(SPC)拮抗剂在需要抗菌肽表达恢复的哺乳动物中制备了将抗菌肽的表达恢复至正常水平的药物。 鞘氨醇磷酰胆碱(SPC)拮抗剂的筛选方法包括以下步骤:用鞘糖基磷酰胆碱或其衍生物处理物体以抑制抗菌肽的表达; 并用SPC拮抗剂候选物质处理对象,分析对象中抗菌肽的表达恢复水平。

    헥소사민 화합물 또는 이의 약학적으로 허용 가능한 염을포함하는, 수술 후 유착의 예방 또는 치료용 약학 조성물
    67.
    发明公开
    헥소사민 화합물 또는 이의 약학적으로 허용 가능한 염을포함하는, 수술 후 유착의 예방 또는 치료용 약학 조성물 有权
    用于预防或治疗包含十四烷基胺化合物或其药学上可接受的药物的术后粘合剂的药物组合物

    公开(公告)号:KR1020080050760A

    公开(公告)日:2008-06-10

    申请号:KR1020060121432

    申请日:2006-12-04

    CPC classification number: A61K31/7008 A61K9/06 A61K9/10 A61K9/20 A61K9/48

    Abstract: A hexosamine derivative is provided to show excellent intra-abdominal fibrinous adhesion inhibitory activity, thereby being usefully used for preventing or treating post-operative adhesion. A pharmaceutical composition for preventing or treating post-operative adhesion such as intra-abdominal fibrinous adhesion comprises a hexosamine compound represented by a formula(1) or a pharmaceutically acceptable salt thereof as an active ingredient, wherein the active ingredient is selected from the group consisting of galactosamine, D-(+)-glucosamine hydrochloride, and D-(+)-galactosamine hydrochloride.

    Abstract translation: 提供了一种己糖胺衍生物以显示优异的腹内纤维粘附抑制活性,从而有效地用于预防或治疗术后粘连。 用于预防或治疗术后粘连(例如腹内纤维粘连)的药物组合物包含由式(1)表示的己糖胺化合物或其药学上可接受的盐作为活性成分,其中活性成分选自 的半乳糖胺,D - (+) - 葡糖胺盐酸盐和D - (+) - 半乳糖胺盐酸盐。

Patent Agency Ranking